The Neuroconnective Endophenotype, A New Approach Toward Typing Functional Neurological Disorder: A Case-Control Study 2024 Bulbena-Vilarrasa et al

Discussion in 'Other psychosomatic news and research' started by Andy, Oct 11, 2024.

  1. Andy

    Andy Committee Member

    Messages:
    22,850
    Location:
    Hampshire, UK
    Abstract

    Objective:
    Functional neurological disorder (FND) is a core neuropsychiatric condition that includes both physical and mental symptoms. Recently, a validated clinical phenotype termed neuroconnective endophenotype (NEP), which includes several physical and psychological characteristics together with joint hypermobility (hypermobility spectrum disorders), was found at a significantly higher frequency among patients with anxiety. The purpose of the present study was to examine the presence of the NEP among patients with FND.

    Methods:
    The authors conducted a multicenter case-control study comprising 27 FND patients and 27 healthy control participants (matched by sex and age) ages 13 to 58 years. Eight questionnaires were administered. Proportional differences were examined with Student’s t tests, one-way analyses of variance, and chi-square tests.

    Results:
    Differences between FND patients and control participants were observed. FND patients had higher sensory sensitivity, increased prevalence of hypermobility features (including relevant physical signs and symptoms), greater frequency of polarized behaviors, a greater number of both psychiatric and physical comorbidities, and an increase in the characteristics and sensations typical of anxiety. Particularly striking was the presence of the hypermobility spectrum in more than 75% of FND patients compared with 15% among control participants.

    Conclusions:
    FND patients presented higher scores in all five dimensions included in the NEP. Thus, this phenotype, solidifying the original association between anxiety and the hypermobility spectrum, could help to identify an FND subtype when evaluating and managing FND patients, because it provides a new global view of patients’ physical and mental symptoms.

    Paywall, https://psychiatryonline.org/doi/10.1176/appi.neuropsych.20240016
     
  2. Turtle

    Turtle Senior Member (Voting Rights)

    Messages:
    130
    Nep in Dutch means fake. FND was bad, but a NEP diagnose (first sentence) will not be embrased by Dutch patients, I think.
     
  3. rvallee

    rvallee Senior Member (Voting Rights)

    Messages:
    13,432
    Location:
    Canada
    Embarrassing nonsense. Always the same old nonsense. Psychosomatic medicine is an infinitely growing cancer.
     
  4. Hutan

    Hutan Moderator Staff Member

    Messages:
    28,925
    Location:
    Aotearoa New Zealand
    1. Find 27 patients with a diagnosis of FND, a diagnosis of anxiety and who seem to have hypermobility.
    2. Find 27 healthy patients without any of these issues

    3. Give both groups questionnaires covering somaticisation, anxiety and hypermobility

    4. Find that the patient group ticks more boxes in the questionnaires than the healthy group

    5. Announce that you have found that the so-called 'validated clinical phenotype of neuroconnective endophenotype' is prevalent in FND patients.

    That's like carefully selecting oranges for the fruit bowl and then acting surprised that there are so many oranges in the fruit bowl.
     
    ukxmrv, Joan Crawford, Amw66 and 8 others like this.
  5. rvallee

    rvallee Senior Member (Voting Rights)

    Messages:
    13,432
    Location:
    Canada
    Re-enactement of this process:

    [​IMG]
     
  6. Hutan

    Hutan Moderator Staff Member

    Messages:
    28,925
    Location:
    Aotearoa New Zealand
    :D exactly.
     
  7. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    5,600
    Location:
    Aotearoa New Zealand
    One clinic specifically with patients dx with psychogenic nonepileptic pseudoseizures, the other an anxiety clinic having dx'ed them with FND (consecutively). No surprise anxiety is seen more frequently in patients partly recruited from an anxiety clinic...

    Apologies if I'm missing the point: the inclusion criteria didn't mention hypermobility. Are we assuming there's a confounder that makes an FND diagnosis more likely in those thought to be hypermobile?

    Needed to meet all 4. Note that 30% also had fibromyalgia, 41% had "CFS" and 11% had POTS - which might be suggested as "better explained by any other medical disorder."

    Odd definition of healthy, though they did not have psychiatric diagnoses. 7% had fibromyalgia, 4% had "CFS", 8% had POTS, 11% had vertigo, 4% had IBS. (Not sure how either 7% or 8% is achieved out of 27.)

    Screenshot 2024-10-13 at 10.03.32 AM copy.jpg
     
    oldtimer, Hutan and Peter Trewhitt like this.
  8. Sean

    Sean Moderator Staff Member

    Messages:
    7,896
    Location:
    Australia
    6. Make completely unjustified assumptions and assertions about causal relationships.

    7. Profit!
     
  9. Hutan

    Hutan Moderator Staff Member

    Messages:
    28,925
    Location:
    Aotearoa New Zealand
    It was paywalled, so I couldn't see how they recruited. But, I thought the assumption that the bias towards recruitment for hypermobility would have crept in was pretty safe. Having read the excerpts, I still think that. These people devised the study thinking that hypermobility was important in FND, as part of a 'validated clinical phenotype'.

    Given that the authors were playing with this idea, I imagine that they had been satisfying their curiosity by asking their patients about hypermobility, probably in the same consultation where they promoted the study. It would have been easy to provide extra encouragement to people that were thought to fit the phenotype.

    They had to match the 27 participants - there's plenty of scope there to not try so hard to find a control match for someone who isn't going to support your hypothesis.

    Also, importantly, if you were a patient and you were told about this study, you would be a lot more likely to participate if you believed that hypermobility was part of your problems. And you would be a lot more likely to believe that if you had heard about the study. It sounds as though they had trouble recruiting, so the selection bias may have been quite pronounced.

    I'm not ruling out the possibility that some sort of hypermobility might have a connection with symptoms that are often taken to be anxiety. I just don't think this study is good enough to tell us anything reliable about that.

    How odd. And there we were, thinking that FND was 'everywhere', that it was of plague proportions in health systems.
     
    Last edited: Oct 13, 2024 at 6:44 AM
  10. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    5,600
    Location:
    Aotearoa New Zealand
    Yes I almost bolded that and tagged Dave30th !
     
    Peter Trewhitt, Sean and Hutan like this.
  11. Amw66

    Amw66 Senior Member (Voting Rights)

    Messages:
    6,724
    It's always worked before , why change a winning formula ?
     
    rvallee, oldtimer, Hutan and 2 others like this.
  12. rvallee

    rvallee Senior Member (Voting Rights)

    Messages:
    13,432
    Location:
    Canada
    But the 'experts' keep saying that it's one of the most common disorders seen in health care, possibly the most common problem. That seems to conflict a bit. Just a tiny bit. It's both one of the most common disorders and also rare. You can be anything if you want to.

    Also, what I was thinking that this comes from an anxiety clinic and they hand out 'anxiety' questionnaires (which convenient happen to ask overlapping questions):
    See, you know that any cat in that box is an asshole because it says so on the box.
    - Person who made the box​
     

Share This Page